About
Brachytherapy, alpha-particle radiotherapy
Areas of Focus
Categories
Medical ImplantRadiopharmaceuticalsMidwest
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
4
As Collaborator
2
Total Enrollment
723
By Phase
PHASE1/PHASE2: 3EARLY_PHASE1: 2PHASE1: 1
By Status
RECRUITING: 3ACTIVE_NOT_RECRUITING: 2COMPLETED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
Today
Hover over trial bars to see details
Recent Trials
NCT06710756Lead Sponsor
Lead-212 PSV359 Therapy for Patients With Solid Tumors
PHASE1/PHASE2Recruiting
112 participants
Started: Apr 28, 2025 · Completed: May 28, 2032
NCT06148636Collaborator
A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors
EARLY_PHASE1Active, not recruiting
24 participants
Started: Nov 10, 2023 · Completed: Nov 20, 2027
NCT05636618Lead Sponsor
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Neuroendocrine Tumors
PHASE1/PHASE2Recruiting
260 participants
Started: Sep 27, 2023 · Completed: Dec 26, 2029
NCT05655312Lead Sponsor
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
PHASE1/PHASE2Recruiting
300 participants
Started: Jun 1, 2023 · Completed: Dec 31, 2029
NCT05111509Collaborator
A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent
EARLY_PHASE1Active, not recruiting
20 participants
Started: Aug 22, 2022 · Completed: Jun 30, 2026
Locations (1)
Headquarters
Coralville, IA, United States
Map
Loading map...